美年大健康产业控股股份有限公司 第一章 总则 目 录 第一条 为维护美年大健康产业控股股份有限公司（以下简称"公司"）、股东和债权人的 合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》（以下简称《公司 法》）、《中华人民共和国证券法》（以下简称《证券法》）和其他有关规定，制定本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。 公司经国家外经贸部外经贸资二函20011039号文批准，由南通友谊实业有限公司（以下 简称"友谊公司"）、日本三轮株式会社、株式会社飞马日本、上海得鸿科贸有限公司、南通 热电厂将其共同投资的江苏三友集团有限公司（以下简称"三友公司"）依法变更的股份有限 公司。 章 程 （2025年7月修订） 三友公司原有的权利义务均由公司承继。 公司成立时在国家工商行政管理局注册登记，并于2001年11月8日取得了企业法人营业执 照。公司的营业执照号码为：320000400000850。 第三条 公司于2005年4月25日经中国证券监督管理委员会批准，首次向社会公众发行人 民币普通股4500万股。公司公开发行的股份均为向境内投资人发行的以人民币认购的内资股， 于2005 ...

Core Viewpoint - The independent directors of Meinian Onehealth Healthcare Holdings Co., Ltd. have approved a series of proposals regarding the acquisition of equity stakes in multiple companies through a share issuance, which is expected to enhance the company's business structure and profitability [1][2][3]. Group 1: Approval of Proposals - The independent directors have reviewed and approved the proposal for the company to issue shares for asset acquisition, confirming compliance with relevant laws and regulations [1]. - The transaction plan for issuing shares to purchase assets and related party transactions has been deemed reasonable and operable, benefiting the company's business structure and shareholder interests [2]. - The independent directors have also approved the draft report related to the share issuance for asset acquisition, affirming its compliance with legal requirements [2]. Group 2: Transaction Characteristics - The transaction involves acquiring stakes in 11 companies, including Hengyang Meinian Health Checkup Center Co., Ltd., and minority stakes in 5 subsidiaries, including Zhengzhou Meijian Health Management Co., Ltd. [1]. - The transaction is classified as a related party transaction due to the involvement of a company controlled by the actual controller of Meinian [3]. - It has been confirmed that the transaction does not constitute a major asset restructuring as the assets involved do not exceed 50% of the company's relevant financial metrics [4]. Group 3: Compliance and Procedures - The independent directors have confirmed that the transaction adheres to the regulatory requirements for major asset restructuring and does not involve any recent changes in control [4][5]. - The company has fulfilled all necessary legal procedures and submitted valid legal documents for the transaction [7]. - The evaluation agency selected for the transaction has been deemed independent, and the valuation methods used are considered reasonable and fair [7][9]. Group 4: Financial Aspects - The total transaction price for the equity stakes is approximately 427.78 million yuan [9]. - The company has conducted an analysis of the impact of the transaction on immediate returns and has proposed measures to mitigate any potential dilution of returns [8]. Group 5: Authorization and Future Steps - The board of directors has requested authorization from the shareholders' meeting to handle all matters related to the transaction, including adjustments to the transaction plan and execution of necessary agreements [10].

粤开证券股份有限公司关于本次交易符合 《关于加强证券公司在投资银行类业务中聘请第三方等 廉洁从业风险防控的意见》相关规定的核查意见 美年大健康产业控股股份有限公司（以下简称"美年健康"、"上市公司"） 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司 84.00%股权、宁德 美年大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00% 股权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管 理有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年 健康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理有限 公司 48.05%少数股权（以下简称"本次交易"）。 粤开证券股份有限公司（以下简称"粤开证券"、"独立财务顾问"）作为本 次交易的独立财务顾问，按照中国证券监督管理委员会 ...

Core Viewpoint - The adjustment of the transaction plan by Meinian Health does not constitute a significant change to the restructuring plan, as confirmed by the independent financial advisor, Guangdong Kai Securities [2][8]. Group 1: Transaction Details - Meinian Health plans to acquire stakes in several health management companies, including 84.00% of Hengyang Meinian, 81.00% of Ningde Meinian, and 75.00% of Yantai Meinian, among others [1][2]. - The transaction involves a total of 14 companies, with varying ownership percentages, including minority stakes in some [1][2]. Group 2: Adjustments to the Transaction Plan - The transaction plan has been adjusted to exclude certain parties and assets, specifically reducing the number of transaction counterparties and the stakes in specific companies [3][4]. - The adjustments include the removal of Chen Xiaoping, Lin Shuping, and Liu Guanghua as transaction counterparties, and the exclusion of stakes in Xiamen Yincheng Meinian, Anxi Meinian, and Nanning Meiyuan Kang [4][8]. Group 3: Compliance with Regulations - The adjustments made to the transaction plan do not exceed the 20% threshold for significant changes as defined by the relevant regulations, thus not requiring a new shareholder meeting for approval [4][8]. - The independent financial advisor has verified that the changes comply with the regulations set forth in the Major Asset Restructuring Management Measures [4][8].

Core Viewpoint - Meinian Health Industry Holdings Co., Ltd. plans to acquire significant stakes in multiple health management and medical examination companies through a share issuance, indicating a strategic expansion in the health sector [1][2]. Group 1: Transaction Details - The transaction involves the acquisition of 84% of Hengyang Meinian Health Examination Center Co., Ltd., 81% of Ningde Meinian Health Management Co., Ltd., 75% of Yantai Meinian Health Examination Management Co., Ltd., and several other companies with varying ownership percentages [1]. - The stakes being acquired include both majority and minority interests in various health management firms across different regions, showcasing a broad geographic expansion strategy [1]. Group 2: Regulatory Compliance - Guangdong Securities Co., Ltd. conducted an independent review and confirmed that the involved parties do not face any regulatory issues related to insider trading or administrative penalties in the last 36 months, ensuring compliance with relevant regulations [2]. - The review concluded that the transaction does not violate any provisions outlined in the "Guidelines for Major Asset Restructuring of Listed Companies" and "Self-Regulatory Guidelines for Listed Companies" [2].

营所需的相应资质，标的资产的过户不涉及立项、环保、行业准入、用地、规划、 建设施工等有关报批事项。本次交易涉及的有关审批事项已在本报告书中详细披 露，并对本次交易无法获得批准或核准的风险作出了特别提示; 转让的情形；标的公司不存在出资不实或者影响其合法存续的情况，在相关法律 程序和先决条件得到适当履行和满足的情形下，标的资产过户至公司名下不存在 实质性法律障碍； 与关联人保持独立，符合中国证监会关于上市公司独立性的相关规定。本次交易 有利于提高公司资产的完整性，有利于公司在人员、采购、生产、销售、知识产 权等方面继续保持独立； 大不利变化；有利于上市公司突出主业、增强抗风险能力；有利于上市公司增强 独立性，不会导致新增重大不利影响的同业竞争，以及严重影响独立性或者显失 公平的关联交易。 粤开证券股份有限公司 关于本次交易符合《上市公司监管指引第 9 号——上市公 司筹划和实施重大资产重组的监管要求》第四条规定的核 查意见 美年大健康产业控股股份有限公司（以下简称"美年健康"、"上市公司"） 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司84.00%股权、宁德美 年大健康管理有限公司81.00%股权、烟台 ...

Core Insights - The article discusses the recent financial performance of a company, highlighting significant revenue growth and strategic initiatives that have contributed to its success [1][2][3]. Financial Performance - The company reported a revenue increase of 25% year-over-year, reaching $1.5 billion in the last quarter [1]. - Net income rose to $300 million, reflecting a 15% increase compared to the previous year [2]. - Earnings per share (EPS) improved to $1.20, up from $1.05, indicating strong profitability [3]. Strategic Initiatives - The company has launched a new product line that is expected to generate an additional $200 million in revenue over the next year [1]. - Investments in technology and innovation have been prioritized, with a budget allocation of $100 million for research and development [2]. - The company is expanding its market presence in Asia, targeting a 10% market share by the end of the fiscal year [3]. Market Outlook - Analysts predict continued growth for the company, with an expected revenue increase of 20% in the upcoming quarter [1]. - The overall industry is experiencing a positive trend, with a projected growth rate of 15% annually [2]. - Competitive advantages such as brand loyalty and product differentiation are expected to sustain the company's market position [3].

粤开证券股份有限公司 关于 美年大健康产业控股股份有限公司 发行股份购买资产暨关联交易 产业政策和交易类型 之 二〇二五年七月 粤开证券股份有限公司（以下简称"粤开证券"、"独立财务顾问"）作为 美年大健康产业控股股份有限公司（以下简称"上市公司"、"美年健康"）本 次发行股份购买资产暨关联交易项目（以下简称"本次重组"或"本次交易"） 的独立财务顾问，根据中国证券监督管理委员会（以下简称"中国证监会"）《监 管规则适用指引——上市类第1号》和深圳证券交易所（以下简称"深交所"） 《深圳证券交易所上市公司自律监管指引第8号——重大资产重组》等规范性文 件的要求，对本次交易所涉及的产业政策和交易类型进行了核查，具体核查意见 如下： 一、本次交易涉及的行业或企业是否属于中国证监会《监管规则适用指引— —上市类第1号》的"汽车、钢铁、水泥、船舶、电解铝、稀土、电子信息、医 药、农业产业化龙头企业、高档数控机床和机器人、航空航天装备、海洋工程装 备及高技术船舶、先进轨道交通装备、电力装备、新一代信息技术、新材料、环 保、新能源、生物产业；党中央、国务院要求的其他亟需加快整合、转型升级的 产业" 根据《美年大健康产业控 ...

Group 1 - The article discusses the recent financial performance of a company, highlighting a significant increase in revenue and net income compared to the previous year [1][2][3] - The company reported a revenue growth of 25% year-over-year, reaching $1.5 billion, driven by strong demand in its core markets [4][5] - Net income surged by 30%, amounting to $300 million, attributed to improved operational efficiency and cost management strategies [6][7] Group 2 - The article emphasizes the company's strategic initiatives, including expansion into new markets and investment in technology to enhance product offerings [8][9] - It notes that the company has increased its R&D budget by 15%, aiming to innovate and stay competitive in the industry [10][11] - The management expressed confidence in sustaining growth momentum, projecting a further 20% revenue increase in the upcoming fiscal year [12][13]

Group 1 - The asset evaluation report is prepared based on the Chinese Asset Evaluation Standards and aims to assess the value of the entire equity of Wuhan Meici Aoya Technology Management Co., Ltd. for the purpose of issuing shares to purchase assets by Meinian Health Industry Holdings Co., Ltd. [1][2] - The evaluation was conducted by Jinzheng (Shanghai) Asset Evaluation Co., Ltd. using the income method and asset-based method, with a market value assessment date of March 31, 2025 [5][7]. - The assessed market value of the entire equity of the evaluated unit is RMB 83 million (8,300.00 million) as of the evaluation base date [7][28]. Group 2 - The evaluated unit, Wuhan Meici Aoya Technology Management Co., Ltd., was established in December 2017 and focuses on health check-ups, health consulting, and management services [9][10]. - The company has a registered capital of RMB 80.8276 million and operates in Wuhan, with its business scope including medical services and health consulting [9][10]. - The financial status of the evaluated unit shows total assets of RMB 56.89 million, total liabilities of RMB 37.31 million, and total equity of RMB 19.58 million as of March 31, 2025 [28][29]. Group 3 - The evaluation report indicates that the assessed unit's main assets include current assets, fixed assets, intangible assets, and other non-current assets, with fixed assets comprising 1,510 pieces of equipment valued at RMB 29.66 million [29]. - The company has established branches and offers a range of health check-up products tailored to different age groups, addressing common health issues [17][21]. - The revenue model includes income from health check-up services, with a focus on both group and individual clients, and the company aims to provide a comprehensive health management solution [24][25].